http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014034871-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
filingDate | 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2014034871-A1 |
titleOfInvention | Preventive or therapeutic agent for dyslipidemia |
abstract | It is an object of the present invention to provide a medicament for the prevention and / or treatment of dyslipidemia. The present invention relates to the following general formula (I) [Chemical 1] (In the formula, R1, R2, R3, and R4 each represent a hydrogen atom, a trifluoromethyl group, or a C1-3 alkyl group.) Or a salt thereof as an active ingredient for use in the prevention and / or treatment of dyslipidemia. Among these compounds, (S) -N- (2- (2- (2-cyanopyrrolidin-1-yl) -2-oxoethylamino) -2-methylpropyl) -2-methylpyrazolo [1,5- a] Pyrimidine-6-carboxamide (generic name: anagliptin) is preferred. |
priorityDate | 2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.